Early Diagnosis of Tularemia by Flow Cytometry, Czech Republic, 2003–20151
, Pavlína Tinavská, Olga Dvořáčková, Pavlína Filipová, Věra Hnetilová, Pavel Žampach, Květoslava Batistová, Václav Chmelík, Amanda E. Semper, and Nick J. Beeching
Author affiliations: České Budějovice Hospital, České Budějovice, Czech Republic (A. Chrdle, P. Tinavská, P. Filipová, V. Hnetilová, P. Žampach, V. Chmelík); University of South Bohemia Faculty of Health and Social Sciences, České Budějovice, Czech Republic (A. Chrdle, O. Dvořáčková); Royal Liverpool University Hospital, Liverpool, UK (A. Chrdle, N.J. Beeching); Písek Hospital, Písek, Czech Republic (K. Batistová); Public Health England, Porton Down, UK (A.E. Semper); National Institute for Health Research Health Protection Research Unit in Emerging and Zoonotic Infections, Liverpool, UK (A.E. Semper; N.J. Beeching); Liverpool School of Tropical Medicine, Liverpool (N.J. Beeching)
Figure 5. Comparison of percentages of CD3+ lymphocytes with CD4–/CD8– phenotype in peripheral blood samples from patients with probable or confirmed tularemia cases (n = 64, 2003–2015) and controls (n = 342, 2012–2015), Czech Republic. Boxes indicate interquartile ranges (IQRs), horizontal lines within boxes indicate medians, whiskers indicate range values <1.5× the IQR limits, and circles indicate outliers (i.e., values >1.5× times the IQR limits). The percentage of CD3+/CD4–/CD8– T cells is significantly higher in cases than controls (Mann-Whitney U test, p<0.0001).
Page created: September 17, 2019
Page updated: September 17, 2019
Page reviewed: September 17, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.